Literature DB >> 3886219

Complement changes in falciparum malaria infection.

P Phanuphak, M Hanvanich, R Sakulramrung, P Moollaor, V Sitprija, D Phanthumkosol.   

Abstract

Complement profiles were sequentially studied in 183 Thai adults infected with Plasmodium falciparum. On the first day of admission, CH50, C1q, C4 and C3 were low in 65%, 8%, 19% and 62% of cases, respectively. All patients with low C1q or C4 also had low C3 and CH50. Simultaneous reduction of C1q, C4, C3 and CH50 were found in 10 instances. Factor B was not reduced in any of the patients indicating that only the classical pathway is activated during acute falciparum malaria infection. The incidence and the degree of hypocomplementaemia were higher in patients with cerebral, renal and hepatic complications although significant difference was seen only for C3. After 3-4 days of effective anti-malarial treatment, normalization of C1q and C4 was found in almost all instances whereas C3 and CH50 remained low in 27% and 54% of the cases, respectively. Normalization of C3 was achieved at 4 weeks after discharge while low CH50 still persisted. The reasons for the persistently low CH50 remain unknown.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886219      PMCID: PMC1576927     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  THE COMPLEMENT CONTENT OF HUMAN SERA WITH ESPECIAL REFERENCE TO MALARIA.

Authors:  A D Dulaney; J B Priest; M L Almeda; B Parker
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

2.  Activation of classical and alternate complement pathways in acute falciparum malaria.

Authors:  B Petchclai; R Chutanondh; S Hiranras; W Benjapongs
Journal:  J Med Assoc Thai       Date:  1977-04

3.  Complement activation in children with acute malaria.

Authors:  B M Greenwood; M J Brueton
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

4.  IgM antibodies to red cells and autoimmune anemia in patients with malaria.

Authors:  E B Rosenberg; G T Strickland; S L Yang; G E Whalen
Journal:  Am J Trop Med Hyg       Date:  1973-03       Impact factor: 2.345

5.  Complement in acute experimental malaria. II. Alterations in the components of complement.

Authors:  N R Cooper; B J Fogel
Journal:  Mil Med       Date:  1966-09       Impact factor: 1.437

6.  Autoantibodies in falciparum malaria: a sequential study in 183 Thai patients.

Authors:  P Phanuphak; S Tirawatnpong; M Hanvanich; W Panmuong; P Moollaor; S Vejjajiva; V Sitprija; R Intaraprasert; D Phanthumkosol
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria.

Authors:  C Adam; M Géniteau; M Gougerot-Pocidalo; P Verroust; J Lebras; C Gibert; L Morel-Maroger
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

8.  Immunoglobulins and C3 levels in Plasmodium vivax infection and their relationship to haemagglutination antibody titres.

Authors:  N K Ganguly; R E Chandanani; R C Mahajan; S Sharma; V Vasudeva
Journal:  Indian J Med Res       Date:  1980-04       Impact factor: 2.375

9.  Circulating and tissue-bound immune complex formation in murine malaria.

Authors:  C H June; C E Contreras; L H Perrin; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

10.  Relationship of serum complement levels to events of the malarial paroxysm.

Authors:  F A Neva; W A Howard; R H Glew; W A Krotoski; A A Gam; W E Collins; J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

View more
  9 in total

1.  Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites.

Authors:  P R Taylor; E Seixas; M J Walport; J Langhorne; M Botto
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso.

Authors:  C Boudin; B Chumpitazi; M Dziegiel; F Peyron; S Picot; B Hogh; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

3.  Complement C1s cleaves PfEMP1 at interdomain conserved sites inhibiting Plasmodium falciparum cytoadherence.

Authors:  Yvonne Azasi; Leanne M Low; Ashley N Just; Sai S R Raghavan; Christian W Wang; Paola Valenzuela-Leon; J Alexandra Rowe; Joseph D Smith; Thomas Lavstsen; Louise Turner; Eric Calvo; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

4.  New inflammation-related biomarkers during malaria infection.

Authors:  Fikregabrail Aberra Kassa; Marina Tiemi Shio; Marie-Josée Bellemare; Babacar Faye; Momar Ndao; Martin Olivier
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

5.  KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite.

Authors:  Minako Ikoma; Soren Gantt; Corey Casper; Yuko Ogata; Qing Zhang; Ryan Basom; Michael R Dyen; Timothy M Rose; Serge Barcy
Journal:  PLoS One       Date:  2018-02-09       Impact factor: 3.240

6.  The Complement System Contributes to Functional Antibody-Mediated Responses Induced by Immunization with Plasmodium falciparum Malaria Sporozoites.

Authors:  Marije C Behet; Liriye Kurtovic; Geert-Jan van Gemert; Celine M Haukes; Rianne Siebelink-Stoter; Wouter Graumans; Marga G van de Vegte-Bolmer; Anja Scholzen; Jeroen D Langereis; Dimitri A Diavatopoulos; James G Beeson; Robert W Sauerwein
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

7.  The impact of genetic susceptibility to systemic lupus erythematosus on placental malaria in mice.

Authors:  Michael Waisberg; Christina K Lin; Chiung-Yu Huang; Mirna Pena; Marlene Orandle; Silvia Bolland; Susan K Pierce
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

8.  Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors.

Authors:  Matthew Brudner; Marshall Karpel; Calli Lear; Li Chen; L Michael Yantosca; Corinne Scully; Ashish Sarraju; Anna Sokolovska; M Reza Zariffard; Damon P Eisen; Bruce A Mungall; Darrell N Kotton; Amel Omari; I-Chueh Huang; Michael Farzan; Kazue Takahashi; Lynda Stuart; Gregory L Stahl; Alan B Ezekowitz; Gregory T Spear; Gene G Olinger; Emmett V Schmidt; Ian C Michelow
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

9.  The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement.

Authors:  Thiago F A Rosa; Ansgar Flammersfeld; Che J Ngwa; Meike Kiesow; Rainer Fischer; Peter F Zipfel; Christine Skerka; Gabriele Pradel
Journal:  Cell Microbiol       Date:  2015-11-12       Impact factor: 3.715

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.